wattyl jotun alusea antifouling
wattyl australia pty ltd - triphenyl tin fluoride | hydrocarbon solvent | unknown 5 - antifouling
international awlcraft antifouling
akzo nobel pty limited - cuprous oxide; diuron; liquid hydrocarbon - paint - cuprous oxide mineral-copper active 610.0 g/l; diuron urea-substituted active 49.0 g/l; liquid hydrocarbon solvent other 470.0 g/l - antifouling - boat - exterior (antifouling) - fouling - for antifouling on boats
international biolux new technology micron extra high strength self polishing antifouling
akzo nobel pty limited - copper present as cuprous oxide; copper present as cuprous oxide; copper present as cuprous oxide; copper present as cuprous oxide; dichlofluanid; dichlofluanid; dichlofluanid; dichlofluanid - paint - copper present as cuprous oxide mineral-copper active 759.4 g/l; copper present as cuprous oxide mineral-copper active 602.6 g/l; copper present as cuprous oxide mineral-copper active 737.9 g/l; copper present as cuprous oxide mineral-copper active 768.8 g/l; dichlofluanid sulfanyl active 16.4 g/l; dichlofluanid sulfanyl active 13.0 g/l; dichlofluanid sulfanyl active 15.9 g/l; dichlofluanid sulfanyl active 16.6 g/l - antifouling - boat - exterior (antifouling) - marine growth | barnacles | fresh-water fouling organisms | marine fouling organisms | mussels
international biolux new technology micron extra high strength self polishing antifouling
akzo nobel pty limited - cuprous oxide; cuprous oxide; diuron; diuron - paint - cuprous oxide mineral-copper active 700.0 g/l; cuprous oxide mineral-copper active 900.0 g/l; diuron urea-substituted active 70.0 g/l; diuron urea-substituted active 60.0 g/l - antifouling - boat - exterior (antifouling) - marine fouling
international cruiser superior ablative antifouling for aluminium
akzo nobel pty limited - cuprous thiocyanate | diuron - antifouling - boat - exterior (antifouling) - fouling - for antifouling on boats
patent blue v
patent blue v -
patent blue v
promedico ltd - patent blue v sodium - solution for injection - patent blue v sodium 25 mg/ml - other diagnostic agents - marking lymph vessels and arterial regions.marking sentinel nodes before biopsy in patients with operable breast cancer.
nolvadex tablet 10 mg
astrazeneca singapore pte ltd - tamoxifen citrate 15.2 mg eqv tamoxifen - tablet, film coated - 10 mg - tamoxifen citrate 15.2 mg eqv tamoxifen 10 mg
nolvadex-d tablet 20 mg
astrazeneca singapore pte ltd - tamoxifen citrate 30.4mg eqv tamoxifen - tablet, film coated - 20 mg - tamoxifen citrate 30.4mg eqv tamoxifen 20 mg
isosulfan blue injection, solution
mylan institutional llc - isosulfan blue (unii: 39n9k8s2a4) (isosulfan blue inner salt - unii:ns6q291771) - isosulfan blue 10 mg in 1 ml - isosulfan blue injection 1% upon subcutaneous administration, delineates lymphatic vessels draining the region of injection. it is an adjunct to lymphography in: primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities. isosulfan blue injection 1% is contraindicated in those individuals with known hypersensitivity to triphenylmethane or related compounds. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when isosulfan blue injection 1% is administered to a nursing mother. safety and effectiveness of isosulfan blue injection 1% in children have not been established.